Please use this identifier to cite or link to this item:
|Title:||Stereotactic Body Radiotherapy (SBRT) for primary and recurrent head and neck tumors||Authors:||Lim, C.M.
|Keywords:||Head and neck tumors
Stereotactic radiation therapy
|Issue Date:||May-2013||Citation:||Lim, C.M., Clump, D.A., Heron, D.E., Ferris, R.L. (2013-05). Stereotactic Body Radiotherapy (SBRT) for primary and recurrent head and neck tumors. Oral Oncology 49 (5) : 401-406. ScholarBank@NUS Repository. https://doi.org/10.1016/j.oraloncology.2012.12.009||Abstract:||Stereotactic Body Radiotherapy (SBRT) is increasingly used to treat a variety of head and neck tumors as a result of its highly conformal dose distributions and stereotactic spatial accuracy in delivery. Our experience and other previous reports have shown that SBRT is technically feasible, well-tolerated and compares favorably to other alternatives of salvage therapy in the management of patients with recurrent and/or previously irradiated head and neck cancers. Furthermore, it has the advantage of a shorter treatment schedule, greater compliance, and safe delivery in the outpatient setting. This affords an opportunity to introduce SBRT as a definitive treatment in select patients. This review presents an overview of the use of SBRT for managing head and neck tumors by highlighting the existing indications and the expanding role of SBRT in managing these patients. © 2012 Elsevier Ltd. All rights reserved.||Source Title:||Oral Oncology||URI:||http://scholarbank.nus.edu.sg/handle/10635/125880||ISSN:||13688375||DOI:||10.1016/j.oraloncology.2012.12.009|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.